Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo

Table 2

Clinical characteristics of C57BL/6 mice.

Parameters	Control group ()	Metformin 8 weeks ()
Body weight (g)	19.4 ± 0.55	22.26 ± 1.1
Fasting blood glucose (mmol/L)	13.6 ± 0.1	16 ± 0.08
Fasting serum triglyceride (mmol/L)	0.613 ± 0.018	1.25 ± 0.01
Fasting serum cholesterol (mmol/L)	1.34 ± 0.01	1.84 ± 0.02